Stock Events

Stock Events

RenovaCare 

$0
6
+$0+0% Wednesday 20:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
3,335
Avg. Volume
0
Mkt Cap
8,735.2
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

18NovExpected
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
-0.03
-0.02
-0.01
-0
Expected EPS
N/A
Actual EPS
-0.0046

Financials

-Profit Margin
Unprofitable
2016
2017
2018
2019
2020
2021
0Revenue
-8.94MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RCAR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers products in wound care and tissue regeneration, directly competing with RenovaCare's skin regeneration technology.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation provides medical devices for orthopaedics, which includes wound management and regenerative medicine, overlapping with RenovaCare's market.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its subsidiary Ethicon, offers advanced wound care products, competing in the same space as RenovaCare.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops medical devices that include wound healing technologies, making it a competitor in the regenerative medicine field.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare, which includes solutions for wound care and regeneration, competing with RenovaCare's offerings.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. has a broad portfolio in biopharmaceuticals, including regenerative medicine, which puts it in competition with RenovaCare.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products including treatments in regenerative medicine, competing with RenovaCare.
Novartis
NVS
Mkt Cap237.61B
Novartis AG focuses on innovative medicines, with divisions in regenerative medicine that compete with RenovaCare's skin regeneration technology.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. offers advanced recovery and therapy products in the areas of wound care and regenerative medicine, making it a competitor.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. designs, manufactures, and markets robotic products for surgery, indirectly competing with RenovaCare by offering alternative treatments in tissue repair and regeneration.

About

RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.
Show more...
CEO
Mr. Harmel S. Rayat
Employees
1
Country
US
ISIN
US75988J1060

Listings

OTC Link
US
RCAR

0 Comments

Share your thoughts

FAQ

What is RenovaCare stock price today?▼
The current price of RCAR is $0 USD — it has increased by +0% in the past 24 hours. Watch RenovaCare stock price performance more closely on the chart.
What is RenovaCare stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange RenovaCare stocks are traded under the ticker RCAR.
Is RenovaCare stock price growing?▼
RCAR stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year RenovaCare has showed a +0% increase.
What is RenovaCare market cap?▼
Today RenovaCare has the market capitalization of 8,735.2
What were RenovaCare earnings last quarter?▼
RCAR earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is RenovaCare revenue for the last year?▼
RenovaCare revenue for the last year amounts to 0 USD.
What is RenovaCare net income for the last year?▼
RCAR net income for the last year is -8.94M USD.
How many employees does RenovaCare have?▼
As of April 02, 2026, the company has 1 employees.
In which sector is RenovaCare located?▼
RenovaCare operates in the Health Care sector.
When did RenovaCare complete a stock split?▼
RenovaCare has not had any recent stock splits.
Where is RenovaCare headquartered?▼
RenovaCare is headquartered in Scottsdale, US.